|1.||Chen, Jian Jeffrey: 7 articles (06/2011 - 01/2007)|
|2.||Biswas, Kaustav: 6 articles (10/2011 - 05/2007)|
|3.||Sirois, Pierre: 6 articles (09/2011 - 08/2003)|
|4.||Gabra, Bichoy H: 5 articles (02/2006 - 08/2003)|
|5.||Sun, Hong: 4 articles (10/2011 - 05/2007)|
|6.||Arik, Leyla: 4 articles (10/2011 - 05/2007)|
|7.||Askew, Benny C: 4 articles (06/2011 - 05/2007)|
|8.||Kumar, Gondi: 4 articles (06/2011 - 05/2007)|
|9.||Hungate, Randall W: 4 articles (06/2011 - 05/2007)|
|10.||Pan, Jinhe: 3 articles (08/2015 - 03/2015)|
02/01/2006 - "We discuss the efficacy of selective antagonists of the inducible bradykinin B1 receptor (BKB1-R) subtype against hyperalgesia assessed by various nociceptive tests. "
01/01/2015 - "The bradykinin B1 receptor antagonist BI113823 reverses inflammatory hyperalgesia by desensitization of peripheral and spinal neurons."
05/02/2005 - "Hyperalgesia in non-obese diabetic (NOD) mice: a role for the inducible bradykinin B1 receptor."
04/15/2005 - "Absence of diabetic hyperalgesia in bradykinin B1 receptor-knockout mice."
12/01/2004 - "Pathways for the bradykinin B1 receptor-mediated diabetic hyperalgesia in mice."
06/04/2012 - "Orally active peptidic bradykinin B1 receptor antagonists engineered from a cyclotide scaffold for inflammatory pain treatment."
08/12/2010 - "Bradykinin B1 receptor antagonists as potential therapeutic agents for pain."
08/01/2010 - "The bradykinin B1 receptor has been shown to mediate pain response and is rapidly induced upon injury. "
01/01/2008 - "Small molecule bradykinin B1 receptor antagonists as potential therapeutic agents for pain."
01/01/2007 - "Targeting the bradykinin B1 receptor to reduce pain."
|3.||Coronary Artery Disease (Coronary Atherosclerosis)
03/01/2014 - "Genetic variation and gender determine bradykinin type 1 receptor responses in human tissue: implications for the ACE-inhibitor-induced effects in patients with coronary artery disease."
03/01/2014 - "The efficacy of the ACE (angiotensin-converting enzyme) inhibitor perindopril in coronary artery disease [EUROPA (European trial on reduction of cardiac events with perindopril in stable coronary artery disease) study] is associated with the rs12050217 A/G single nucleotide polymorphism in the B1 receptor (bradykinin type 1 receptor) gene. "
|4.||Sarcoma (Soft Tissue Sarcoma)
|5.||Bone Neoplasms (Bone Cancer)
11/01/2005 - "With a mouse model of bone cancer pain we demonstrate that pharmacologic blockade of the bradykinin B1 receptor is effective in reducing bone cancer pain-related behaviors, suggesting that B1 antagonists might be useful in attenuating bone cancer pain in humans."
11/01/2005 - "In our model of bone cancer, which involves the injection and confinement of 2472 sarcoma cells to the mouse femur, pharmacologic blockade of the bradykinin B1 receptor is effective in reducing pain-related behaviors at both early and advanced stages of bone cancer. "
|2.||Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
|5.||Bradykinin B2 Receptor
|6.||Bradykinin Receptors (Bradykinin Receptor)
|8.||GTP-Binding Proteins (G-Protein)
|9.||Bradykinin B1 Receptor
|10.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|1.||Chinese Traditional Medicine (Traditional Chinese Medicine)